These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24733614)

  • 1. Elevated neurofilament light chain (NFL) mRNA levels in prediabetic peripheral neuropathy.
    Celikbilek A; Tanik N; Sabah S; Borekci E; Akyol L; Ak H; Adam M; Suher M; Yilmaz N
    Mol Biol Rep; 2014 Jun; 41(6):4017-22. PubMed ID: 24733614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies.
    Mariotto S; Farinazzo A; Magliozzi R; Alberti D; Monaco S; Ferrari S
    J Peripher Nerv Syst; 2018 Sep; 23(3):174-177. PubMed ID: 29974556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma neurofilament light chain in immune-mediated neurological disorders (IMND) detected by immunomagnetic reduction (IMR).
    Huang KY; Wu CL; Chang YS; Huang WY; Su FC; Lin SW; Chien YY; Weng WC; Wei YC
    Brain Res; 2023 Dec; 1821():148587. PubMed ID: 37739331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels.
    Mariotto S; Carta S; Bozzetti S; Zivelonghi C; Alberti D; Zanzoni S; Filosto M; Fusina S; Monaco S; Castellani F; Mantovani A; Cavallaro T; Briani C; Ferrari S
    J Neurol; 2020 Oct; 267(10):2881-2887. PubMed ID: 32462349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of neurofilament light chain, neuron-specific enolase and S100 calcium-binding protein B during acute bacterial meningitis: a prospective cohort study.
    Grønhøj MH; Sejbaek T; Hansen RW; Larsen L; Dahl M; Schierbeck J; Poulsen FR
    Infect Dis (Lond); 2021 Jun; 53(6):409-419. PubMed ID: 33583314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament light chain levels indicate acute axonal damage under bortezomib treatment.
    Cebulla N; Schirmer D; Runau E; Flamm L; Gommersbach S; Stengel H; Zhou X; Einsele H; Reinhold AK; Rogalla von Bieberstein B; Zeller D; Rittner H; Kortüm KM; Sommer C
    J Neurol; 2023 Jun; 270(6):2997-3007. PubMed ID: 36802032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting poor neurological outcomes following out-of-hospital cardiac arrest using neuron-specific enolase and neurofilament light chain in patients with and without haemolysis.
    Abdi Isse Y; Frikke-Schmidt R; Wiberg S; Grand J; Obling LER; Meyer ASP; Kjaergaard J; Hassager C; Meyer MAS
    Eur Heart J Open; 2023 Jul; 3(4):oead078. PubMed ID: 37646044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of Neurofilament Light Chain and Nerve Ultrasound in Leprotic Neuropathy.
    Nasr-Eldin YK; Cartwright MS; Hamed A; Ali LH; Abdel-Nasser AM
    J Ultrasound Med; 2023 Dec; 42(12):2803-2813. PubMed ID: 37661825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity.
    Meregalli C; Fumagalli G; Alberti P; Canta A; Chiorazzi A; Monza L; Pozzi E; Carozzi VA; Blennow K; Zetterberg H; Cavaletti G; Marmiroli P
    Arch Toxicol; 2020 Jul; 94(7):2517-2522. PubMed ID: 32333051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum neurofilament light chain as a prognostic marker in postanoxic encephalopathy.
    Disanto G; Prosperetti C; Gobbi C; Barro C; Michalak Z; Cassina T; Kuhle J; Casso G; Agazzi P
    Epilepsy Behav; 2019 Dec; 101(Pt B):106432. PubMed ID: 31375414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with chronic insomnia disorder have increased serum levels of neurofilaments, neuron-specific enolase and S100B: does organic brain damage exist?
    Zhang P; Tan CW; Chen GH; Ge YJ; Xu J; Xia L; Wang F; Li XY; Kong XY
    Sleep Med; 2018 Aug; 48():163-171. PubMed ID: 29957487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neurofilament light chain as outcome marker for intensive care unit patients.
    Fisse AL; Pitarokoili K; Leppert D; Motte J; Pedreiturria X; Kappos L; Gold R; Kuhle J; Yoon MS
    J Neurol; 2021 Apr; 268(4):1323-1329. PubMed ID: 33098034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological symptoms and neuronal damage markers in acute COVID-19: Is there a correlation? A pilot study.
    Sahin BE; Celikbilek A; Kocak Y; Ilanbey B; Saltoglu GT; Konar NM; Hizmali L
    J Med Virol; 2023 Jan; 95(1):e28240. PubMed ID: 36262025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament Light Chains in Systemic Amyloidosis: A Systematic Review.
    Berends M; Nienhuis HLA; Adams D; Karam C; Luigetti M; Polydefkis M; Reilly MM; Sekijima Y; Hazenberg BPC
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neurofilament light chain concentrations are elevated in youth-onset type 2 diabetes and associated with neuropathy.
    Fridman V; Sillau S; Ritchie A; Bockhorst J; Coughlan C; Araya P; Espinosa JM; Smith K; Lange EM; Lange LA; Ghormli LE; Drews KL; Zeitler P; Reusch JEB
    J Peripher Nerv Syst; 2023 Sep; 28(3):460-470. PubMed ID: 37341347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent selective suppression of light (NFL) and medium (NFM) but not heavy (NFH) molecular weight neurofilament mRNA levels in acute aluminum neurotoxicity.
    Strong MJ; Mao K; Nerurkar VR; Wakayama I; Yanagihara R; Garruto RM
    Mol Cell Neurosci; 1994 Aug; 5(4):319-26. PubMed ID: 7804601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma neurofilament light chain concentration in the inherited peripheral neuropathies.
    Sandelius Å; Zetterberg H; Blennow K; Adiutori R; Malaspina A; Laura M; Reilly MM; Rossor AM
    Neurology; 2018 Feb; 90(6):e518-e524. PubMed ID: 29321234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of vitamin D supplementation on peripheral neuropathy in a sample of Egyptian prediabetic individuals.
    Reda Halawa M; Zaky Ahmed I; Fawzy Abouelezz N; Roushdy Mohamed N; Hany Abdelaziz Khalil N; Mahmoud Ali Hendawy L
    F1000Res; 2021; 10():817. PubMed ID: 35222988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.